News
MedInvest is hosting a MedTech, AI & Digital Health Conference December 10-11, 2025 in New York City. NIH National Cancer Institute’s Michael Salgaller will be speaking. He will be discussing NIH as a premier technology transfer partner, how the process at the NIH works, and answering questions
Register today for an NIH webinar discussing an opportunity to license or collaborate on a new method of RNA extraction that increases sensitivity and improves safety. Inventors at the National Eye Institute (NEI) have developed a novel improved sample preparation method that eliminates the need for
The CDC is searching for a licensee or collaborator for a new method to prevent HIV infection that has lower drug costs and lowers exposure to possible drug side effects. The current leading product to prevent HIV infection is daily pre-exposure prophylaxis (PrEP). However, many people find it
Inventors at the National Cancer Institute (NCI) have created a tool for developing new targeted therapies or enhancing patient stratification in transcriptomic multi-arm trials. This tool, named SELECT, uses a computational, precision-oncology framework that uses the tumor’s whole transcriptome to